Clinical Trials Directory

Trials / Completed

CompletedNCT00308724

Treating Late-Life Generalized Anxiety Disorder (GAD) in Primary Care

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
148 (actual)
Sponsor
Baylor College of Medicine · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether cognitive behavior therapy (CBT) is effective in the treatment of generalized anxiety disorder (GAD) in adults age 60 and older in a primary care setting.

Detailed description

Generalized Anxiety Disorder (GAD) is one of the most common anxiety disorders among older adults. Anxiety in older adults is associated with decreased physical activity, poorer self-perceptions of health, decreased life satisfaction, and increased loneliness. Because many older adults with anxiety seek assistance in a medical setting, treatment has been primarily pharmacological. There is, however, limited evidence of the effectiveness of psychotropic medications. Given the potential difficulties in prescribing psychotropic medications in later life (e.g., increased adverse effects, potential drug interactions), psychosocial treatments may be important alternative or adjuncts. The treatment phase of this study lasts 10 weeks, during which patients will be randomly assigned to either cognitive behavior therapy (CBT) or usual care. Follow-up will last 12 months after treatment completion, during which time patients will complete telephone assessments.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive Behavior Therapy8 to 10 in person CBT sessions up to 60 minutes in duration within a 12 week time period
BEHAVIORALTelephone check-inBiweekly telephone calls to monitor symptom severity, an enhanced Usual Care condition

Timeline

Start date
2004-03-01
Primary completion
2008-01-01
Completion
2015-04-01
First posted
2006-03-30
Last updated
2024-03-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00308724. Inclusion in this directory is not an endorsement.